Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiotherapy (IMRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation: A Retrospective Cohort Study

M. Iocolano,N. Yegya-Raman,X. Wang, C. Friedes,S. H. Lee, L. Duan, B. Li,W. P. Levin,K. A. Cengel, C. Langer,R. Cohen,L. Sun, C. Aggarwal, A. Doucette,Y. Xiao, K. Teo, S. E. O'Reilly, W. Zou, C. B. Simone, S. J. Feigenberg

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览2

暂无评分

摘要

Among pts with LA-NSCLC treated with cCRT in the era of ICI consolidation, PBT was associated with fewer acute unplanned hospitalizations compared to IMRT. There was no difference in G3+ pneumonitis, G3+ esophagitis, PFS or OS.

查看译文

关键词

proton beam therapy,immune checkpoint inhibitor,radiotherapy,cancer,intensity-modulated,non-small,la-nsclc

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要